Clinical Trial Applications - Approved: Filter, Search, and view applications


Clear
Extended search...

Page 55 of 58, showing 10 Applications out of 576 total, starting on record 541, ending on 550

# Protocol No Study Title Investigator(s) & Site(s) Date Approved

541.

ECCT/25/07/03   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   
Principal Investigator(s)
1. Joyce Akuka
Site(s) in Kenya
1. Migori County Referral Hospital (Migori county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
4. Kisii Teaching and Referral Hospital (Kisii county)
 
14-04-2026 View

542.

ECCT/25/07/04   PROPS Trial
    Efficacy of probiotic supplementation in preterm and small for gestational age infants. A multi-centre, placebo-controlled, individually-randomised trial   (Probiotics in preterm and small for gestational age infants, PROPS trial)   
Principal Investigator(s)
1. Mourine Ikol
Site(s) in Kenya
1. Kisii Teaching and Referral Hospital (Kisii county)
2. Homabay County Referral Hospital (Homa Bay county)
3. Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
4. Migori County Referral Hospital (Migori county)
 
20-04-2026 View

543.

ECCT/25/07/05   Cabotegravir + Rilpivirine Lon
    A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Longacting Combination Therapy Studie   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Aga Khan University Hospital (Nairobi City county)
2. Moi University Clinical Research Centre (Elgeyo/Marakwet county)
3. KEMRI-WRP (Kericho county)
4. University of Nairobi - Jaramogi Oginga Odinga Teaching and Referral Hospital (Kisumu county)
 
31-10-2025 View

544.

ECCT/25/07/06   SASI
    Randomized Controlled Trial of Surfactant Administered via Supraglottic Airway Device (SALSA) Compared to Endotracheal Tube (InSurE) on Survival without Mechanical Ventilation in Preterm Neonates with Respiratory Distress Syndrome in Sub-Saharan Africa   
Principal Investigator(s)
1. Mary Waiyego Kariuki
Site(s) in Kenya
Kenyatta national Hospital
 
31-10-2025 View

545.

ECCT/25/07/08   REACH
    Heat-stable carbetocin for the treatment of postpartum haemorrhage: a phase III, randomized, double-blind, active controlled, multicountry, multicentre,   non-inferiority trial   
Principal Investigator(s)
1. Zahida Qureshi
Site(s) in Kenya
1. Machakos county hospital (Machakos county)
2. Pumwani maternity hospital (Nairobi City county)
3. Nakuru Level 5 Hospital (Nakuru county)
 
17-12-2025 View

546.

ECCT/25/08/01   MK-8527 as HIV-1 PrEP in Women
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure   Prophylaxis in Women       
Principal Investigator(s)
1. Maricianah Onono
Site(s) in Kenya
1. KEMRI-RCTP KISUMU (Kisumu county)
2. Kargeno Research and Policy Hub KEMRI-CMR KISUMU (Kisumu county)
3. KEMRI-PHRD, Thika (Kiambu county)
4. UW KNH - Rachuonyo County Hospital (Homa Bay county)
 
21-11-2025 View

547.

ECCT/25/08/02   MK-8527-010
    A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Efficacy and Safety of MK-8527 Oral Once-Monthly as HIV-1 Preexposure Prophylaxis in Women.   
Principal Investigator(s)
1. Elizabeth Anne Bukusi
Site(s) in Kenya
1. KEMRI CMR RCTP (Kisumu county)
 
21-11-2025 View

548.

ECCT/25/08/03   Cabotegravir + Rilpivirine Lon
    A Phase 4, Open-Label, Rollover Study to Provide Continued Access to Cabotegravir Long-acting Injection and Rilpivirine Long-acting Injection to Participants Living with Human   Immunodeficiency Virus Type 1 (HIV-1) Infection Who Participated in Long acting Combination Therapy Studies   
Principal Investigator(s)
1. Loice Achieng Ombajo
Site(s) in Kenya
1. Aga Khan University Hospital (Nairobi City county)
2. Moi University Clinical Research Centre (Uasin Gishu county)
3. KEMRI-WRP (Kericho county)
4. Kenyatta National Hospital Comprehensive Care Centre (Nairobi City county)
 
15-12-2025 View

549.

ECCT/25/08/04   MK-8527-010 PrEP
    A Phase 3, Randomized, Active-Controlled, Double-blind Clinical Study to Evaluate the Efficacy and Safety of Oral MK-8527 Once-Monthly as HIV-1 Preexposure Prophylaxis in Cisgender Women    
Principal Investigator(s)
1. Nelly Rwamba Mugo
Site(s) in Kenya
1. KEMRI-CCR PHRD Thika (Kiambu county)
 
25-11-2025 View

550.

ECCT/25/08/05   Floral roll over study
    An open-label, multi-centre, rollover study to characterise long-term safety and efficacy of etavopivat in adults, adolescents and children who have sickle cell disease or thalassaemia and have completed a treatment period in an etavopivat study.   
Principal Investigator(s)
1. Dr. Isaac Tsikhutsu
Site(s) in Kenya
1. KEMRI WALTER REED KERICHO (Kericho county)
2. Center for Research in Therapeutic Sciences (CREATES) (Kisumu county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrudes Childrens Hospital (Nairobi City county)
5. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county)
6. KEMRI/ WRAIR-Africa, Kombewa Clinical Research Center (Kisumu county)
7. KEMRI Kondele Children\'s Hospital (Kisumu county)
 
09-02-2026 View